Johnson & Johnson's shares fell 3% after a U.S. judge rejected its $10 billion settlement to resolve talc-related cancer lawsuits, marking its third failed attempt and highlighting...
Johnson & Johnson's shares dropped over 3% after a US judge rejected its $10 billion settlement to resolve talc-related cancer lawsuits, marking its third failed attempt. The compa...
Johnson & Johnson's shares fell over 3% after a US judge rejected its $10 billion settlement proposal for talc-related lawsuits, marking its third failed attempt to resolve the lit...
Johnson & Johnson's shares fell over 3% after a judge rejected its $10 billion talc settlement proposal, marking its third failed attempt to resolve lawsuits alleging its products ...
Johnson & Johnson's shares fell 3% after a judge rejected its $10 billion settlement proposal for talc-related cancer lawsuits, marking another legal setback for the company.
Johnson & Johnson's shares fell over 3% after a US judge rejected its $10 billion settlement offer for talc-related lawsuits, marking its third failed attempt to resolve the litiga...
Johnson & Johnson's shares dropped over 3% after a U.S. judge rejected its $10 billion settlement proposal for talc-related lawsuits, marking its third failed attempt to resolve th...
